X T L Biopharmaceuticals reported $138K in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Bioline Rx USD 11.38M 1.22M Sep/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025
X T L Biopharmaceuticals USD 138K 30K Dec/2024